ACOG
Price
$9.97
Change
+$0.01 (+0.10%)
Updated
Jul 25 closing price
Capitalization
159.72M
BLTE
Price
$62.24
Change
+$0.39 (+0.63%)
Updated
Jul 25 closing price
Capitalization
2.03B
11 days until earnings call
Interact to see
Advertisement

ACOG vs BLTE

Header iconACOG vs BLTE Comparison
Open Charts ACOG vs BLTEBanner chart's image
Alpha Cognition
Price$9.97
Change+$0.01 (+0.10%)
Volume$30.77K
Capitalization159.72M
Belite Bio
Price$62.24
Change+$0.39 (+0.63%)
Volume$20.6K
Capitalization2.03B
ACOG vs BLTE Comparison Chart in %
Loading...
ACOG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACOG vs. BLTE commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACOG is a Hold and BLTE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (ACOG: $9.97 vs. BLTE: $62.24)
Brand notoriety: ACOG and BLTE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACOG: 36% vs. BLTE: 40%
Market capitalization -- ACOG: $159.72M vs. BLTE: $2.03B
ACOG [@Biotechnology] is valued at $159.72M. BLTE’s [@Biotechnology] market capitalization is $2.03B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACOG’s FA Score shows that 0 FA rating(s) are green whileBLTE’s FA Score has 0 green FA rating(s).

  • ACOG’s FA Score: 0 green, 5 red.
  • BLTE’s FA Score: 0 green, 5 red.
According to our system of comparison, ACOG is a better buy in the long-term than BLTE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACOG’s TA Score shows that 3 TA indicator(s) are bullish while BLTE’s TA Score has 4 bullish TA indicator(s).

  • ACOG’s TA Score: 3 bullish, 5 bearish.
  • BLTE’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both ACOG and BLTE are a bad buy in the short-term.

Price Growth

ACOG (@Biotechnology) experienced а -0.20% price change this week, while BLTE (@Biotechnology) price change was +2.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

ACOG is expected to report earnings on May 15, 2025.

BLTE is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLTE($2.03B) has a higher market cap than ACOG($160M). ACOG YTD gains are higher at: 69.270 vs. BLTE (-1.363). ACOG has higher annual earnings (EBITDA): -11.4M vs. BLTE (-43.31M). ACOG has higher revenues than BLTE: ACOG (2.93M) vs BLTE (0).
ACOGBLTEACOG / BLTE
Capitalization160M2.03B8%
EBITDA-11.4M-43.31M26%
Gain YTD69.270-1.363-5,083%
P/E RatioN/AN/A-
Revenue2.93M0-
Total Cash45.5MN/A-
Total Debt2.21MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ACOGBLTE
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 17 days ago
84%
Bullish Trend 13 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 9 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
ACOG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QDROF0.030.01
+32.04%
Quadro Resources Ltd.
PUBC0.070.02
+28.91%
Purebase Corporation
AMBBY15.41N/A
N/A
Ambu A/S
WFICF13.14N/A
N/A
Wall Financial Corp.
PWCDF40.55-0.03
-0.08%
Power Corp. of Canada

ACOG and

Correlation & Price change

A.I.dvisor tells us that ACOG and VRCA have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACOG and VRCA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACOG
1D Price
Change %
ACOG100%
+0.10%
VRCA - ACOG
31%
Poorly correlated
-5.57%
COGT - ACOG
27%
Poorly correlated
-0.98%
BLTE - ACOG
26%
Poorly correlated
+0.63%
IPHA - ACOG
24%
Poorly correlated
-0.23%
BCRX - ACOG
21%
Poorly correlated
N/A
More

BLTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLTE has been loosely correlated with RAIN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BLTE jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLTE
1D Price
Change %
BLTE100%
+0.63%
RAIN - BLTE
48%
Loosely correlated
+0.44%
ACOG - BLTE
24%
Poorly correlated
+0.10%
LENZ - BLTE
23%
Poorly correlated
-5.33%
NAMS - BLTE
23%
Poorly correlated
+0.90%
AGIO - BLTE
22%
Poorly correlated
+0.88%
More